没有这样对解决细菌抗药性上升问题一以贯之的提醒，更不要说及时公布进展状况，世界各国就有可能受到其他问题干扰，从而错失这次推进必要改革以阻止耐药菌感染上升的转瞬即逝的机遇。
Without such a consistent reminder of the need to tackle AMR, not to mention transparency about progress, the world could become sidetracked and miss the rapidly closing window of opportunity to deliver the changes needed to stop the rise of drug-resistant infections.